If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHill & Smith Regulatory News (HILS)

Share Price Information for Hill & Smith (HILS)

Share Price is delayed by 15 minutes
Get Live Data
2,850.00    10.00 (0.35%)
Bid:
2,845.00
Ask:
2,855.00
Spread: 10.00 (0.351%)
Market Cap: £2.23b
HILS Live PriceLast checked at - London Stock Exchange

Intraday Hill & Smith Share Chart

Director/PDMR Shareholding

20 Sep 2024 10:57

RNS Number : 0656F
Hill & Smith PLC
20 September 2024
 

Hill & Smith PLC ('Hill & Smith' or 'the Company')

20 September 2024

Grant of Awards under the Hill & Smith 2023 Long-Term Incentive Plan ('LTIP')

On 19 September 2024 (the 'Grant Date') the Company granted an award in the form of a nil cost option over a total of 24,552 ordinary shares in the Company to Rutger Helbing, the Company's Chief Executive Officer, under the LTIP (the 'Award').

The Award will vest based on the achievement of relative Total Shareholder Return (50%) and Underlying EPS Growth (50%) performance conditions measured over a 3-year performance period. The detailed performance conditions will be provided in the 2024 Directors' Remuneration Report.

The Award will (subject to the achievement of the performance conditions) vest following the end of the performance period but will not ordinarily be exercisable until the end of a further two-year holding period.

The number of ordinary shares over which the award was granted was based on a share price of 2,046 pence per ordinary share, being the average mid-market closing share price for the three business days prior to the grant date, as derived from the London Stock Exchange daily official list.

As a result of these transactions Rutger Helbing holds share options over 24,552 ordinary shares in the Company.

 

Enquiries:

Karen Atterbury

Company Secretary

0121 704 7430

 

2024 LTIP Award

1.

Details of the person discharging managerial responsibilities/person closely associated

(a)

Name

Rutger Helbing

2.

Reason for the notification

(a)

Position/status

Chief Executive Officer

(b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer

(a)

Name

Hill & Smith PLC

(b)

LEI

2138003A3ISGQZBOWI83

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

(a)

Description of the Financial Instrument

Ordinary shares of £0.25 each

Identification code of the Financial Instrument

GB0004270301

(b)

Nature of the transaction

Grant of 2024 LTIP award (in the form of a nil-cost option to acquire ordinary shares in the Company)

(c)

Price(s) and volume(s)

Price(s)

Volume

Nil

24,552

(d)

Aggregated information:

- Aggregated volume

- Price

 

Price(s)

Volume

Nil

24,552

(e)

Date of the transaction

19 September 2024

(f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKKBPCBKKACB
Date   Source Headline
8th Oct 200712:51 pmRNSDirector/PDMR Shareholding
5th Oct 20073:34 pmRNSDirector/PDMR Shareholding
1st Oct 20072:24 pmRNSDirector Appointment
28th Sep 20072:22 pmRNSTotal Voting Rights
7th Sep 20079:55 amRNSInterim Report
3rd Sep 200712:36 pmRNSDirector/PDMR Shareholding
3rd Sep 20077:00 amRNSInterim Results
31st Aug 200710:15 amRNSTotal Voting Rights
17th Jul 20079:37 amRNSBlocklisting Interim Review
2nd Jul 20074:42 pmRNSEGM Resolution
2nd Jul 20073:49 pmRNSDirector/PDMR Shareholding
2nd Jul 200711:28 amRNSResult of EGM
27th Jun 200712:41 pmRNSDirector/PDMR Shareholding
22nd Jun 200711:07 amRNSDirector/PDMR Shareholding
19th Jun 20074:21 pmRNSDirector/PDMR Shareholding
15th Jun 20074:03 pmRNSCirc re Acquisition
11th May 20074:38 pmRNSResult of AGM
11th May 20077:30 amRNSAGM Statement
1st May 20079:28 amRNSTotal Voting Rights
11th Apr 20075:02 pmRNSAnnual Information Update
11th Apr 20074:10 pmRNSHolding(s) in Company
11th Apr 20073:57 pmRNSAnnual Report and Accounts
3rd Apr 20072:24 pmRNSCompany Secretary Change
3rd Apr 200710:22 amRNSTotal Voting Rights
6th Mar 20077:15 amRNSDirectorate Change
6th Mar 20077:02 amRNSFinal Results
1st Mar 20078:21 amRNSAcquisition
28th Feb 20075:23 pmRNSHolding(s) in Company
22nd Feb 20075:36 pmRNSHolding(s) in Company
8th Feb 20071:22 pmRNSHolding(s) in Company
17th Jan 20073:56 pmRNSBlocklisting Interim Review
9th Jan 20077:00 amRNSRe Contract
21st Dec 20064:38 pmRNSPrice Monitoring Extension
20th Dec 20063:26 pmRNSTotal Voting Rights
1st Nov 20067:30 amRNSAcquisition
18th Oct 20063:44 pmRNSDirector/PDMR Shareholding
18th Oct 20063:43 pmRNSDirector/PDMR Shareholding
18th Oct 20063:43 pmRNSDirector/PDMR Shareholding
18th Oct 20063:42 pmRNSDirector/PDMR Shareholding
18th Oct 20063:41 pmRNSDirector/PDMR Shareholding
17th Oct 20064:09 pmRNSHolding(s) in Company
11th Oct 20063:01 pmRNSResult of EGM
4th Oct 20067:00 amRNSResult of Open Offer
20th Sep 20067:30 amRNSZinkinvent update
13th Sep 20065:24 pmRNSInterim Report & Prospectus
12th Sep 20067:30 amRNSPlacing and Open Offer
12th Sep 20067:30 amRNSInterim Results
21st Aug 20061:22 pmRNSBoard Appointment
28th Jul 20062:10 pmRNSHolding(s) in Company
21st Jul 20069:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.